Friday, April 29, 2022 10:27:36 PM
" On April 26, 2022, Joshua Levine and Mordechai Hacham each tendered a letter of resignation from the Board of Directors (the “Board”) of Scopus BioPharma Inc. (the “Company”), effective immediately. A copy of each of Messrs. Levine and Hacham’s letters of resignation which state their reasons for resigning are furnished herewith as Exhibits 99.1 and 99.2, respectively. The Company disagrees with Messrs. Levine and Hacham’s substantive assessments and characterizations set forth in their respective letters of resignation."
Recent SCPS News
- Form 1-Z - • Edgar (US Regulatory) • 02/09/2024 10:15:27 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/19/2024 10:15:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:16:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 09:01:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:00:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/21/2023 09:00:15 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM